Differential expression of the neu transgene in murine mammary tissues

International Journal of Oncology

Volumn 11, Issue 2, 1997, Pages 235-241

  Deckard Janatpour, Kim ^a   Muller, William J ^b   Chodosh, Lewis A ^c   Gardner, Heather P ^c   Marquis, Sandra T ^c   Coffey, Robert ^d   Cardiff, Robert D ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HER 2 neu (c erbB 2); Immunohistochemistry; Mammary gland; Mammary tumor; Transgenic mice

Indexed keywords

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0030747818     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.2.235     Document Type: Article

References (21)

1. Donehower LA, Godleyz LA, Alda CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE: Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9: 882-895, 1995.
2. Cardiff RD and Muller WJ: Transgenic mouse models of mammary tumorigenesis. Cancer Surv 16: 97-137, 1993.
3. Siegel PM, Dankort DL, Hardy WR and Muller WJ: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 14: 7068-7077, 1994.
4. Guy CT, Muthuswamy SK, Soriano P, Cardiff RD and Muller WJ: Activation of c-src tyrosinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8: 23-32, 1994.
5. Overbeek PA, Aguilar-Cordova E, Hanten G, Schaffner DL, Patel P, Lebovitz R and Lieberman MW: Coinjection strategy for visual identification of transgenic mice. Transgenic Res 1: 31-37, 1991.
6. Faerman A, Barash I, Puzis R, Nathan M, Hurwitz D and Shani M: Dramatic heterogeneity of transgene expression in the mammary gland of lactating mice: A model system to study the synthetic activity of mammary epithelial cells. J Histochem Cytochem 7: 461-470, 1995.
7. Dobie KW, Lee M, Fantes JA, Graham E, Clark AJ, Springbett A, Lathe R and McClenaghan M: Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. Proc Natl Acad Sci USA 93: 6659-6664, 1996.
8. Halter SA, Dempsey P, Matsui Y, Stokes MK, Gravesdeal R, Hogan BL and Coffey RJ: Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-α. Characterization of mammary gland and skin proliferations. Am J Pathol 149: 1131-1146, 1992.
9. Tulchin N, Lee FS, Ornstein L, Strauchen JA and Cardiff RD: c-Myc protein distribution: mammary adenocarcinomas of MTV/myc transgenic mice. Int J Oncol 7: 5-9, 1995.
10. Muller WJ, Muthuswamy SK, Webster MA, Cardiff RD and Coffey R: Synergistic interaction of the Neu protooncogene and TGFα in the mammary epithelium of transgenic mice. Mol Cell Biol 16: 5736-5736, 1996.
11. Guy CT, Cardiff RD, Müller WJ: Activated neu induces rapid tumor progression. J Biol Chem 271: 7673-7678, 1996.
12. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD and Muller WJ: Expression of the c-neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582, 1992.
13. Guy CT, Cardiff RD and Muller WJ: Induction of metastatic mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961, 1992.
14. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin G, Abel KJ, Weber BL and Chodosh LA: The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nature Genet 11: 17-26, 1995.
15. Rajan JV, Marquis ST, Gardner HP and Chodosh LA: Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Develop Biol 184: 385-401, 1997.
16. Cardiff RD: The biology of mammary transgenes: Five rules. J Mammary Gland Biol Neoplasia 1: 61-73, 1996.
17. Muller WJ, Sinn E, Pattengale PK, Wallace R and Leder P: Single step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115, 1988.
18. Pattengale PK, Stewart T, Leder A, Sinn E, Muller W, Tepler L, Schmidt E and Leder P: Animal models of human disease: Pathology and molecular-biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. Am J Pathol 135: 39-61, 1989.
19. Morris DW and Cardiff RD: Multistep model of mouse mammary tumor development. Adv Viral Oncol 7: 123-140, 1987.
20. Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G: Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol 147: 1081-1096, 1995.
21. Dati C, Maggiora P, Puech C, Bortoli MD and Escot C: Expression of the erbB-2 proto-oncogene during differentiation of the mammary gland in the rat. Cell Tissue Res 285: 403-410, 1996.